The serum concentration of Eletriptan can be increased when it is combined with Ribociclib. The risk or severity of adverse effects can be increased when Eletriptan is combined with Pipamperone. The metabolism of Eletriptan can be decreased when combined with Octamoxin. The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline. The metabolism of Eletriptan can be decreased when combined with Clozapine. The metabolism of Eletriptan can be decreased when combined with Losartan. The serum concentration of Eletriptan can be increased when it is combined with Isradipine. The metabolism of Eletriptan can be increased when combined with Rifabutin. The metabolism of Eletriptan can be decreased when combined with Quinine. The serum concentration of Eletriptan can be increased when it is combined with Aprepitant. The metabolism of Eletriptan can be decreased when combined with Zucapsaicin. The serum concentration of Eletriptan can be increased when it is combined with Harmaline. The metabolism of Eletriptan can be decreased when combined with Diphenhydramine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Benperidol. The metabolism of Eletriptan can be decreased when combined with Furazolidone. The risk or severity of adverse effects can be increased when Eletriptan is combined with Pimozide. The serum concentration of Eletriptan can be increased when it is combined with Diltiazem. The risk or severity of adverse effects can be increased when Eletriptan is combined with Sumatriptan. The metabolism of Eletriptan can be decreased when combined with Sulfadiazine. The serum concentration of Saxagliptin can be decreased when it is combined with Eletriptan. The risk or severity of adverse effects can be increased when Eletriptan is combined with Metoclopramide. The metabolism of Eletriptan can be decreased when combined with Esomeprazole. The risk or severity of adverse effects can be increased when Eletriptan is combined with Clomipramine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Rizatriptan. The metabolism of Eletriptan can be decreased when combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline. The metabolism of Eletriptan can be decreased when combined with Chloroquine. The serum concentration of Eletriptan can be increased when it is combined with Verapamil. The metabolism of Eletriptan can be decreased when combined with Zafirlukast. The metabolism of Eletriptan can be decreased when combined with Paroxetine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Raclopride. The metabolism of Eletriptan can be decreased when combined with Promazine. The metabolism of Eletriptan can be decreased when combined with Eslicarbazepine acetate. The risk or severity of adverse effects can be increased when Vilazodone is combined with Eletriptan. The serum concentration of Eletriptan can be increased when it is combined with Ketoconazole. The risk or severity of adverse effects can be increased when Eletriptan is combined with Cariprazine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Fluphenazine. The metabolism of Eletriptan can be decreased when combined with Fluvastatin. The risk or severity of adverse effects can be increased when Eletriptan is combined with Linezolid. The metabolism of Eletriptan can be decreased when combined with Rolapitant. The metabolism of Eletriptan can be decreased when combined with Etravirine. The metabolism of Eletriptan can be decreased when combined with Posaconazole. The risk or severity of adverse effects can be increased when Trazodone is combined with Eletriptan. The risk or severity of adverse effects can be increased when Eletriptan is combined with Chlorprothixene. The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram. The metabolism of Eletriptan can be decreased when combined with Methylene blue. The risk or severity of adverse effects can be increased when Eletriptan is combined with Zotepine. The serum concentration of Eletriptan can be increased when it is combined with Lovastatin. The risk or severity of adverse effects can be increased when Eletriptan is combined with Rasagiline. The serum concentration of Eletriptan can be decreased when it is combined with Siltuximab. The risk or severity of adverse effects can be increased when Eletriptan is combined with Olanzapine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Bromocriptine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Methadone. The metabolism of Eletriptan can be increased when combined with Phenytoin. The risk or severity of adverse effects can be increased when Eletriptan is combined with Dapiprazole. The serum concentration of Eletriptan can be increased when it is combined with Sildenafil. The metabolism of Eletriptan can be decreased when combined with Efavirenz. The serum concentration of Eletriptan can be decreased when it is combined with Tocilizumab. The metabolism of Eletriptan can be decreased when combined with Hydracarbazine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Almotriptan. The metabolism of Eletriptan can be increased when combined with Phenobarbital. The metabolism of Eletriptan can be decreased when combined with Sorafenib. The risk or severity of adverse effects can be increased when Eletriptan is combined with Ergonovine. The serum concentration of Rilpivirine can be decreased when it is combined with Eletriptan. The serum concentration of Eletriptan can be increased when it is combined with Vemurafenib. The risk or severity of adverse effects can be increased when Eletriptan is combined with Fencamfamine. The serum concentration of Eletriptan can be increased when it is combined with Ziprasidone. Dolasetron may increase the serotonergic activities of Eletriptan. The metabolism of Eletriptan can be decreased when combined with Metoprolol. The serum concentration of Eletriptan can be increased when it is combined with Itraconazole. The metabolism of Eletriptan can be decreased when combined with Mirabegron. The serum concentration of Eletriptan can be increased when it is combined with Dronedarone. The risk or severity of adverse effects can be increased when Eletriptan is combined with Doxepin. The metabolism of Eletriptan can be decreased when combined with Eliglustat. The risk or severity of adverse effects can be increased when Eletriptan is combined with Buspirone. The metabolism of Eletriptan can be decreased when combined with Bupropion. The metabolism of Eletriptan can be decreased when combined with Dosulepin. The risk or severity of adverse effects can be increased when Eletriptan is combined with Prochlorperazine. The metabolism of Eletriptan can be decreased when combined with Irbesartan. The metabolism of Eletriptan can be decreased when combined with Boceprevir. The metabolism of Eletriptan can be decreased when combined with Armodafinil. The risk or severity of adverse effects can be increased when Eletriptan is combined with Moclobemide. The serum concentration of Eletriptan can be increased when it is combined with Fluvoxamine. The serum concentration of Aripiprazole can be decreased when it is combined with Eletriptan. The risk or severity of adverse effects can be increased when Eletriptan is combined with Cyclobenzaprine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Naratriptan. The risk or severity of adverse effects can be increased when Eletriptan is combined with Zolmitriptan. The metabolism of Eletriptan can be decreased when combined with Ritonavir. The metabolism of Eletriptan can be increased when combined with Fosphenytoin. The risk or severity of adverse effects can be increased when Eletriptan is combined with Ecopipam. The serum concentration of Eletriptan can be increased when it is combined with Cyclosporine. The serum concentration of Eletriptan can be increased when it is combined with Palbociclib. The risk or severity of adverse effects can be increased when Eletriptan is combined with Maprotiline. The metabolism of Eletriptan can be decreased when combined with Omeprazole. The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine. The serum concentration of Eletriptan can be increased when it is combined with Fosamprenavir. The serum concentration of Eletriptan can be increased when it is combined with Amphetamine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Acepromazine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Duloxetine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Tetrahydropalmatine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Desipramine. The serum concentration of Eletriptan can be decreased when it is combined with Bosentan. The risk or severity of adverse effects can be increased when Eletriptan is combined with Ritanserin. The serum concentration of Eletriptan can be increased when it is combined with Nelfinavir. The serum concentration of Eletriptan can be increased when it is combined with Clotrimazole. The metabolism of Eletriptan can be decreased when combined with Safrazine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Tapentadol. The metabolism of Eletriptan can be decreased when combined with Pheniprazine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Remoxipride. The serum concentration of Eletriptan can be increased when it is combined with Simeprevir. The serum concentration of Eletriptan can be increased when it is combined with Cobicistat. The risk or severity of adverse effects can be increased when Eletriptan is combined with Mesoridazine. The metabolism of Eletriptan can be decreased when combined with Saquinavir. The metabolism of Eletriptan can be decreased when combined with Terbinafine. The metabolism of Eletriptan can be increased when combined with Carbamazepine. The serum concentration of Eletriptan can be increased when it is combined with Crizotinib. The risk or severity of adverse effects can be increased when Eletriptan is combined with Reserpine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Protriptyline. The metabolism of Eletriptan can be increased when combined with Rifapentine. The metabolism of Eletriptan can be decreased when combined with Artemether. The risk or severity of adverse effects can be increased when Eletriptan is combined with Procarbazine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Pethidine. Ondansetron may increase the serotonergic activities of Eletriptan. The metabolism of Eletriptan can be increased when combined with Pentobarbital. The metabolism of Eletriptan can be decreased when combined with Fluorouracil. The risk or severity of adverse effects can be increased when Eletriptan is combined with Flupentixol. The risk or severity of adverse effects can be increased when Eletriptan is combined with Melperone. The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin. The metabolism of Eletriptan can be decreased when combined with Cocaine. The risk or severity of adverse effects can be increased when Eletriptan is combined with Perazine. The serum concentration of Eletriptan can be increased when it is combined with Nevirapine.